GlaxoSmithKline Biologicals
Part of GSK
Company
GlaxoSmithKline Biologicals develops 2 assets, the furthest in phase 3, no development reported (sotrovimab in COVID-19). Mostly antibody acting on S.
- 2
- Assets
- Furthest stage
- Phase 3, no development reported
- 0
- Trials
- 0
- Signals
Pipeline
2Monoclonal antibody engineered for immune engagement.
Phase 3, no development reported, Antibody, S, COVID-19, Partner
Binds SARS-CoV-2 spike protein to neutralize the virus, with an engineered Fc region enhancing immune effector functions.
Preclinical, no development reported, Antibody, COVID-19, Partner
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms1
- Trials1
- Signals4
- Similar companies6
Papers
BMJ open, Sep 8, 2026
medRxiv, Sep 3, 2026
JCI insight, Jun 2, 2026
Age-related changes in the immune system and challenges for the development of age-specific vaccines
Annals of medicine, Mar 20, 2025
Innate immune cell activation by adjuvant AS01 in human lymph node explants is age independent
The Journal of clinical investigation, Sep 24, 2024
Nature communications, Aug 4, 2024
medRxiv, Jan 23, 2024
Clinical interventions in aging, Aug 27, 2022
Central European journal of public health, Oct 9, 2021
Vaccination as a preventative measure contributing to immune fitness
NPJ vaccines, Jul 29, 2021
Recombinant Zoster Vaccine Is Efficacious and Safe in Frail Individuals
Journal of the American Geriatrics Society, Nov 17, 2020
Preventing infectious diseases for healthy ageing: The VITAL public-private partnership project
Vaccine, Jul 28, 2020
The journals of gerontology. Series A, Biological sciences and medical sciences, Jun 13, 2020
Novel Technologies to Improve Vaccines for Older Adults
Interdisciplinary topics in gerontology and geriatrics, Apr 20, 2020
Evaluation of two frailty indices, with practical application in a vaccine clinical trial
Human vaccines & immunotherapeutics, Jun 4, 2019
The journals of gerontology. Series A, Biological sciences and medical sciences, Sep 27, 2018
Fighting against a protean enemy: immunosenescence, vaccines, and healthy aging
NPJ aging and mechanisms of disease, Dec 30, 2017
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, Dec 3, 2016